Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Yapan Bio

Explore full profile

Your Collaborative Partner in Process Development and GMP Manufacturing for Vaccines and Biologics/Bio-therapeutics

Hyderabad, IndiaFounded 2019Biotech & Life Sciences
Valuation $10–25M Last recorded · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Yapan Bio and the history behind them.

About Yapan Bio

Yapan Bio is a specialized company operating in the biotechnology sector, focusing on the development and manufacturing of vaccines and biologics, which are medical products derived from living organisms. The company is strategically located in Genome Valley, Hyderabad, India, a premier hub for research and development (R&D) and clean manufacturing.

Yapan Bio serves a diverse range of clients, including pharmaceutical companies, biotech firms, and research institutions. These clients are typically involved in the early-stage research and development of new vaccines and biologics, and they rely on Yapan Bio for its expertise in process development and Good Manufacturing Practice (GMP) manufacturing. GMP refers to regulations that ensure products are consistently produced and controlled according to quality standards.

The company operates in the highly specialized market of biopharmaceutical manufacturing, which requires stringent quality control and regulatory compliance. Yapan Bio offers integrated services that span from early-stage research and process development to scale-up and full-scale GMP manufacturing. This means they help clients optimize their production processes to achieve high product yields, stability, and consistent manufacturing output.

Yapan Bio's business model is service-based. They generate revenue by providing specialized services in process development, optimization, and GMP manufacturing. This includes upstream and downstream development, which refers to the different stages of biopharmaceutical production. Upstream development involves the initial stages of production, such as cell culture, while downstream development involves the purification and formulation of the final product.

In summary, Yapan Bio is a key player in the biopharmaceutical manufacturing industry, offering comprehensive services that help clients bring their vaccines and biologics from the research phase to clinical trials. Their state-of-the-art facilities and expertise make them a valuable partner in this highly regulated and specialized market.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2019
Headquarters
Hyderabad, India
Employees
54
Open positions
None listed
Dealroom signal
80.4/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Vaccines, Biotech and Pharma, Hard Tech
Business model
Manufacturing
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Aug 2026 $7.9M $11M Piramal Pharma ↗
EARLY VC✓Equity / VC Dec 2021 $14M $55M Piramal Healthcare ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Yapan Bio website traffic

Latest recorded traffic for Yapan Bio is 6K monthly website visits, up 328.6% over the last three months. Yapan Bio's team grew 12.5% over the past year.

Latest monthly visits6K 3-month web change+328.6% 1-year team growth+12.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Bonacia (Hefei) Pharmaceutical TechnologyBonacia is a CRO company specializing in clinical research , focusing on professional services for clinical research of innovative drugs, biological drugs and vaccines, and empowering the research and development of new drugs through clinical trial cloud platforms and AI China Operational 34 $14M $55M
Immorna BiotherapeuticsA biotechnology company focused on the development of mRNA-based therapeutics and vaccines Morrisville, United States Operational
Ab&B BiotechFocuses on the research and development of innovative human vaccines and multivalent vaccines Taizhou, China Operational
ZeaVaxxDeveloping a plant-derived nanoparticle that can improve animal vaccines West Lafayette, United States Operational
Normax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness Cork, Ireland Operational
CHA Vaccine InstituteTea vaccine research is a state-of-the-art biotech company developing vaccines and immunotherapys South Korea Operational
RVAC MedicinesMRNA platform company engaged in the research and development of innovative products such as vaccines for diseases Singapore Operational
Curevo VaccineCreating Next Generation Vaccines For Diseases Of Global Importance Seattle, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Piramal Healthcare

Other known investors1 additional known investor

  • Piramal Pharma
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇳 India100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Yapan Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yapan Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.